Financials
- Market Capitalization 4.1 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
21.88
주가매출액비율
3.71
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 1149 | LNTH Lantheus Holdings, Inc. - Common Stock | 100.97 USD | +0.20% | +0.47% | -1.74% | +80.11% | 6.59 B USD | ||
| 1274 | AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.44 USD | -0.57% | -2.41% | -5.42% | +65.31% | 5.57 B USD | ||
| 1783 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.54 USD | +0.73% | +4.14% | -8.58% | -60.17% | 2.74 B USD | ||
| 1837 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.82 USD | +0.21% | -3.07% | -13.14% | -18.85% | 2.55 B USD |